193 related articles for article (PubMed ID: 2567175)
1. Antigenic targets in epimembranous glomerulonephritis. Experimental data and potential application in human pathology.
Ronco P; Allegri L; Brianti E; Chatelet F; Van Leer EH; Verroust P
Appl Pathol; 1989; 7(2):85-98. PubMed ID: 2567175
[TBL] [Abstract][Full Text] [Related]
2. Interaction of antibodies with human glomerular epithelial cells.
Fukatsu A; Yuzawa Y; Olson L; Miller J; Milgrom M; Zamlauski-Tucker MJ; Van Liew JB; Campagnari A; Niesen N; Patel J
Lab Invest; 1989 Oct; 61(4):389-403. PubMed ID: 2796288
[TBL] [Abstract][Full Text] [Related]
3. Antibody-induced redistribution of Heymann antigen on the surface of cultured glomerular visceral epithelial cells: possible role in the pathogenesis of Heymann glomerulonephritis.
Camussi G; Brentjens JR; Noble B; Kerjaschki D; Malavasi F; Roholt OA; Farquhar MG; Andres G
J Immunol; 1985 Oct; 135(4):2409-16. PubMed ID: 3875653
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies to glomerular antigens.
Ronco P; Sahali D; Cittanova ML; van Leer EH; Chatelet F; Verroust P
Nephrol Dial Transplant; 1992; 7 Suppl 1():9-15. PubMed ID: 1362802
[No Abstract] [Full Text] [Related]
5. [Formation of immune deposits during experimental extramembranous glomerulonephritis].
Verroust P; Ronco P
Nephrologie; 1989; 10(3):123-6. PubMed ID: 2691908
[TBL] [Abstract][Full Text] [Related]
6. Heymann nephritis: a model of human membranous glomerulopathy. A study of the role of additional antigens.
van Leer EH; Ronco P; Verroust P; de Roo GM; Hoedemaeker PJ; de Heer E
Nephrol Dial Transplant; 1992; 7 Suppl 1():1-8. PubMed ID: 1362800
[No Abstract] [Full Text] [Related]
7. Isolation and characterization of circulating immune complexes from rats with experimental membranous nephropathy.
Hori MT; Abrass CK
J Immunol; 1990 May; 144(10):3849-55. PubMed ID: 2185315
[TBL] [Abstract][Full Text] [Related]
8. [Etiopathogenesis of membranous nephropathy: is there a correlation between experimental and human pathology?].
Allegri L; Celendo MT; Savazzi G; Garini G; Carnevali ML
Ann Ital Med Int; 1989; 4(4):386-95. PubMed ID: 2487793
[TBL] [Abstract][Full Text] [Related]
9. Heymann antibodies induce complement-dependent injury of rat glomerular visceral epithelial cells.
Camussi G; Salvidio G; Biesecker G; Brentjens J; Andres G
J Immunol; 1987 Nov; 139(9):2906-14. PubMed ID: 3312408
[TBL] [Abstract][Full Text] [Related]
10. Passive Heymann nephritis induced by rabbit antiserum to membrane antigens isolated from rat visceral yolk-sac microvilli.
Leung CC; Cheewatrakoolpong B; O'Mara T; Black M
Am J Anat; 1987 Jun; 179(2):169-74. PubMed ID: 3303894
[TBL] [Abstract][Full Text] [Related]
11. Studies with monoclonal antibodies against brush border antigens in Heymann nephritis.
Bhan AK; Schneeberger EE; Baird LG; Collins AB; Kamata K; Bradford D; Erikson ME; McCluskey RT
Lab Invest; 1985 Oct; 53(4):421-32. PubMed ID: 3900581
[TBL] [Abstract][Full Text] [Related]
12. [Cellular pathology of Heyman nephritis: monoclonal antibodies against the pathogenic antigen Gp 330].
Kerjaschki D
Wien Klin Wochenschr; 1985 Jul; 97(14):581-8. PubMed ID: 3901534
[TBL] [Abstract][Full Text] [Related]
13. Immunocytochemical localization of the Heymann nephritis antigen (GP330) in glomerular epithelial cells of normal Lewis rats.
Kerjaschki D; Farquhar MG
J Exp Med; 1983 Feb; 157(2):667-86. PubMed ID: 6337231
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of passive Heymann glomerulonephritis: chlorpromazine inhibits antibody-mediated redistribution of cell surface antigens and prevents development of the disease.
Camussi G; Noble B; Van Liew J; Brentjens JR; Andres G
J Immunol; 1986 Mar; 136(6):2127-35. PubMed ID: 3485141
[TBL] [Abstract][Full Text] [Related]
15. Renal tubule brush border antigens: failure to confirm a pathogenetic role in human membranous glomerulonephritis.
Thorpe LW; Cavallo T
J Clin Lab Immunol; 1980 Mar; 3(2):125-7. PubMed ID: 7009872
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effects of anti-gp330 and anti-dipeptidyl peptidase type IV antibodies in the induction of glomerular damage.
van Leer EH; de Roo GM; Bruijn JA; Hoedemaeker PJ; de Heer E
Exp Nephrol; 1993; 1(5):292-300. PubMed ID: 7915960
[TBL] [Abstract][Full Text] [Related]
17. [The immune complex pathogenesis of experimental membranous glomerulopathy (Heymann nephritis) and its significance in human glomerular disease].
Kerjaschki D
Verh Dtsch Ges Pathol; 1989; 73():24-35. PubMed ID: 2482609
[TBL] [Abstract][Full Text] [Related]
18. Transcellular transport and membrane insertion of the C5b-9 membrane attack complex of complement by glomerular epithelial cells in experimental membranous nephropathy.
Kerjaschki D; Schulze M; Binder S; Kain R; Ojha PP; Susani M; Horvat R; Baker PJ; Couser WG
J Immunol; 1989 Jul; 143(2):546-52. PubMed ID: 2738403
[TBL] [Abstract][Full Text] [Related]
19. Comparison of antigenic targets involved in antibody-mediated membranous glomerulonephritis in the mouse and rat.
Assmann KJ; Ronco P; Tangelder MM; Lange WP; Verroust P; Koene RA
Am J Pathol; 1985 Oct; 121(1):112-22. PubMed ID: 2413764
[TBL] [Abstract][Full Text] [Related]
20. An immunopathologic study of a 330-kD protein defined by monoclonal antibodies and reactive with anti-RTE alpha 5 antibodies and kidney eluates from active Heymann nephritis.
Ronco P; Neale TJ; Wilson CB; Galceran M; Verroust P
J Immunol; 1986 Jan; 136(1):125-30. PubMed ID: 2415612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]